Gene · 58484
Papers3,844
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,844
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dual Role of Mitogen-Activated Protein Kinase 8 Interacting Protein-1 in Inflammasome and Pancreatic β-Cell Function. | Int J Mol Sci | 2023 | 36902422 | PubTator, text mining | PubMed |
| The Role of NLRP3, a Star of Excellence in Myeloproliferative Neoplasms. | Int J Mol Sci | 2023 | 36902299 | PubTator, text mining | PubMed |
| Metformin, Empagliflozin, and Their Combination Modulate Ex-Vivo Macrophage Inflammatory Gene Expression. | Int J Mol Sci | 2023 | 36902218 | PubTator, text mining | PubMed |
| Imbalanced IL-1B and IL-18 Expression in Sézary Syndrome. | Int J Mol Sci | 2023 | 36902104 | PubTator, text mining | PubMed |
| Update on the Pathogenesis of the Hirschsprung-Associated Enterocolitis. | Int J Mol Sci | 2023 | 36902033 | PubTator, text mining | PubMed |
| Predictive Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Events. | Cancers (Basel) | 2023 | 36900420 | PubTator, text mining | PubMed |
| Non-canonical NLRC4 inflammasomes in astrocytes contribute to glioma malignancy. | Inflamm Res | 2023 | 36899084 | PubTator, text mining | PubMed |
| "Just right" combinations of adjuvants with nanoscale carriers activate aged dendritic cells without overt inflammation. | Immun Ageing | 2023 | 36895007 | PubTator, text mining | PubMed |
| Rescuing fertility during COVID-19 infection: exploring potential pharmacological and natural therapeutic approaches for comorbidity, by focusing on NLRP3 inflammasome mechanism. | J Assist Reprod Genet | 2023 | 36892705 | PubTator, text mining | PubMed |
| Dissection of pyroptosis-related prognostic signature and CASP6-mediated regulation in pancreatic adenocarcinoma: new sights to clinical decision-making. | Apoptosis | 2023 | 36882663 | PubTator, text mining | PubMed |
| Understanding the mechanisms underlying obesity in remodeling the breast tumor immune microenvironment: from the perspective of inflammation. | Cancer Biol Med | 2023 | 36880535 | PubTator, text mining | PubMed |
| Emerging mechanisms and functions of inflammasome complexes in teleost fish. | Front Immunol | 2023 | 36875130 | PubTator, text mining | PubMed |
| A natural goldmine of binding proteins and soluble receptors simplified their translation to blockbuster drugs, all in one decade. | Front Immunol | 2023 | 36875111 | PubTator, text mining | PubMed |
| Comprehensive analysis illustrating the role of PANoptosis-related genes in lung cancer based on bioinformatic algorithms and experiments. | Front Pharmacol | 2023 | 36874021 | PubTator, text mining | PubMed |
| Prognosis and personalized treatment prediction in lung adenocarcinoma: An in silico and in vitro strategy adopting cuproptosis related lncRNA towards precision oncology. | Front Pharmacol | 2023 | 36874011 | PubTator, text mining | PubMed |
| Platelet and ferritin as early predictive factors for the development of macrophage activation syndrome in children with Kawasaki disease: A retrospective case-control study. | Front Pediatr | 2023 | 36873655 | PubTator, text mining | PubMed |
| Case report: The altered rate of monocytic cell death in a patient of Muckle-Wells syndrome with atypical clinical course. | Front Pediatr | 2023 | 36873639 | PubTator, text mining | PubMed |
| Impeding the combination of astrocytic ASCT2 and NLRP3 by talniflumate alleviates neuroinflammation in experimental models of Parkinson's disease. | Acta Pharm Sin B | 2023 | 36873178 | PubTator, text mining | PubMed |
| Systematic investigation of the underlying mechanisms of GLP-1 receptor agonists to prevent myocardial infarction in patients with type 2 diabetes mellitus using network pharmacology. | Front Pharmacol | 2023 | 36865917 | PubTator, text mining | PubMed |
| A new immune checkpoint-associated nine-gene signature for prognostic prediction of glioblastoma. | Medicine (Baltimore) | 2023 | 36862886 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58484/papers?page=32